Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science VC (Venture Capital) Funds in Asia in January 2025

Last updated: Jan 2025 A list of 50 VC (Venture Capital) funds that invest in Life science startups based in Asia. We rank investors based on the number of investments they made in Life science companies from Asia. We update this investor list every month.

Top 50 Life Science VC (Venture Capital) Funds in Asia in January 2025

Investor	Life Science Asia investments
Prox Ventures	9
Hillhouse Investment	6
Qiming Venture Partners	5
HongShan	5
UntroD Capital	4
Osaka University Venture Capital	4
EFung Capital	4
Huagai Capital	4
UTEC - The University of Tokyo Edge Capital Partners	4
Mitsubishi UFJ Capital	4
Nissay Capital	4
Linear Capital	3
EDBI	3
Vinno Capital	3
CD Capital	3
WuXi AppTec	3
SMBC Venture Capital	3
Legend Capital	3
Entrepreneurship Relay Group	3
ASBV	3
Anzu Partners	3
MiraclePlus	3
ULTIMA	3
Nippon Venture Capital	3
BioVenture	3
Lucion	2
Senshu Ikeda Capital	2
Innoangel Fund	2
Green Pine Capital Partners	2
Alibaba Entrepreneurs Fund	2
Hillhouse Ventures	2
Danen Capital	2
Sherpa Healthcare Partners	2
Eight Roads Ventures	2
Eisai	2
Huimei Capital	2
CentreGold Capital	2
Orient Securities Capital Investment	2
Oriental Fortune Capital	2
Loyal Valley Capital	2
Highlight Capital	2
Real Tech Japan	2
BMC	2
Mizuho Capital	2
Matrix Partners China	2
Med-Fine Capital	2
Lilly Asia Ventures	2
BOHE Angel Fund	2
SBI Investment	2
Puhua Capital	2

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Investment focus

Medical, Biotechnology, Health Care
Seed, Funding Round, Series A
China, United States, United Kingdom

Portfolio highlights

Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Series C
China, United States, Singapore

Portfolio highlights

dinii — Dinii is a mobile order platform for take-out shops.
Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Investment focus

Health Care, Biotechnology, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

StepStar — The goal of Stepstar is to "Ten Times the Possibility of Everyone" through Intelligent Step. Step Star firmly creates its own super model and actively uses important resources like
Zhipu AI — Zhipu AI is a data company developing an AI-based large model platform to provide API services. It includes a variety of smart application products such as the scientific and technological information analysis engine and AI cognitive engines to allow users to leverage AI-powered tools to reduce manual labor in digital tasks.
XellSmart — Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China.

We help founders build enduring companies.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

SoSoValue — SoSoValue is a groundbreaking technology that changes the way investors access and evaluate cryptocurrency data. The company intends to level the playing field by ensuring equal access to cutting-edge data technology and insights. SoSoValue leverages strong AI capabilities to provide extensive research tools, real-time data, and a thrivingcommunity for collaborative growth.
Kast — Kast Finance provides open access, financial freedom, and rapid gratification services.
GCL Optoelectronics — GCL Optoelectronics is a supplier of perovskite solar modules, focusing on the R&D and production of perovskite solar modules.

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Investment focus

Manufacturing, Biotechnology, Robotics
Funding Round, Seed, Series A
Japan, Singapore, India

Portfolio highlights

Revorf — Revorf analyzes data and develops AI-related to infectious diseases and healthcare.
MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.
Emulsion Flow Technologies — Emulsion Flow Technologies offers rare metal recycling, utilizing emulsion flow technology, emulsion.

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Investment focus

Biotechnology, Manufacturing, Health Care
Funding Round, Seed, Series A
Japan

Portfolio highlights

Alpha Fusion — Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
Celaid Therapeutics — Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Red Arrow Therapeutics — Red Arrow Therapeutics is a biotech firm that provides systemic cytokine delivery, targeted intratumoral activation, and biological potency.

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series A, Series B, Series C
China, United States, India

Portfolio highlights

Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Germany

Portfolio highlights

Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Funding Round
Japan, United States, Singapore

Portfolio highlights

Estie — Estie is a Development of AI / machine learning algorithm and new business in real estate company.
Liminal — Advanced battery inspection and metrology with ultrasound and machine learning
Eureka Robotics — Eureka Robotics develop robotics technologies and products to automate the mundane, so that humans can focus on the creative.

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Investment focus

Information Technology, Software, Health Care
Funding Round, Series A, Series B
Japan, United States, China

Portfolio highlights

Taian — Taian, which specializes in bridal industry services and software. They also provide ''Concept Marry,'' which allows couples to design invites and seating charts that match their wedding theme, as well as display guest information on Oiwaii.
greenase — greenase is a manufacturer and seller of processed agricultural products.
Grand Central — Grand Central is a consulting company specializing in the sales field.

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Investment focus

Health Care, Internet, Medical
Funding Round, Seed, Series A
Japan, United States, Ethiopia

Portfolio highlights

Castee — Castee provides social collaboration services and also helps with a tool for job requests and overseas projects for creators.
HQ — HQ offers next-generation employee benefits platform.
Qlay — Qlay is an AI-automated global engineer hiring platform

Linear Capital focuses on investment projects in the fields of Data Application, Data Infrastructure and cutting-edge technology applications. they believe that cutting-edge technology is the primary productive force, and they are committed to becoming an important promoter of cutting-edge technology landing industries, realizing FrontierTechnology,

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Angel, Series A
China, Germany, Hong Kong

Portfolio highlights

Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
Swiss-Mile — We collect insights and ease labor by connecting AI with the physical world using autonomous machines.
NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Investment focus

Biotechnology, Software, Health Care
Series C, Series B, Series D
United States, Singapore, China

Portfolio highlights

Island — Meet Island, the Enterprise Browser that gives you control over SaaS governance, visibility and productivity. Secure your critical data and apps with Island.
Zinc Money — A suite of comprehensive solutions to help families navigate international education for their children and ensure a sound financial foundation for their academic journey.
Sunbird Bio — Sunbird Bio, a biotech company, is developing protein-based diagnostic tests that empower diagnosis and treatment of Alzheimer's disease, neurological disorders, and early-stage cancer.

Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.

Investment focus

Manufacturing, Semiconductor, Hardware
Series A, Seed, Series B
China, United States

Portfolio highlights

Glazero Technology — Established in Dec 2020, Glazero is a brand that provides smart home solutions to global markets. It focuses on AIot smart home products, covering smart security, smart lighting and smart cleaning products. Glazero starts from the North American home appliance market, and sells through cross-border e-commerce platforms.
Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Investment focus

Health Care, Biotechnology, Medical Device
Series A, Series B, Seed
China, United States

Portfolio highlights

Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Investment focus

Biotechnology, Pharmaceutical, Health Care
Series A, Series B, Series C
United States, China, Israel

Portfolio highlights

D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Investment focus

Information Technology, Health Care, Software
Funding Round, Series B, Series A
Japan, United States, Singapore

Portfolio highlights

Striemo — Striemo manufactures and develops electric personal mobility. Striemo was founded in 2021 and was headquartered in Tokyo, Japan.
Orbital Lasers — Orbital is a space tech company that provides space debris business to remove debris and a satellite LiDAR business to provide surface data.
RadioNano Therapeutics — RadioNano Therapeutics is developing innovative drugs for Boron Neutron Capture Therapy (BNCT), a type of radiation therapy that utilizes the nuclear reaction between thermal neutrons and boron-10 (¹⁰B) to destroy cancer cells by releasing alpha particles and lithium nuclei.

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Investment focus

Health Care, Medical, Biotechnology
Series B, Series A, Series C
China, United States, South Korea

Portfolio highlights

Volant Aerotech — Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.
Chuangrui Spectrum — Chuangrui Spectrum specializes in the design and manufacture of time-resolved spectroscopy devices and equipment. Chuangrui Spectrum focuses mainly on research and development, as well as the manufacture and marketing of high-end scientific research equipment.
TBSTest Technology — Yuexin Technology is a semiconductor test equipment developer specializing in R&D, production and sales of ultra-large-scale integrated circuit test equipment (ATE). Its main product is SOC test equipment, which is mainly for enterprise users of integrated circuit design, production, packaging and testing. Integrated circuit test equipment andsolutions.

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Investment focus

Manufacturing, Software, Enterprise
Series A, Funding Round, Angel
China

Portfolio highlights

Quick Sensing — Quick Sensing is a high-pressure-pressure automotive sensor developer.
Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.

ASBV focuses on early and mid-term venture capital investments.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Angel
China, Australia, Hong Kong

Portfolio highlights

Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Investment focus

Biotechnology, Software, Manufacturing
Series A, Series B, Funding Round
United States, Canada, Spain

Portfolio highlights

6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Investment focus

Artificial Intelligence, Software, Information Technology
Seed, Angel, Pre-Seed
China, United States, Singapore

Portfolio highlights

TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.

ULTIMA is an investment management firm.

Investment focus

Hardware, Software, Agriculture
Angel, Series A
China

Portfolio highlights

Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Investment focus

Software, Health Care, Information Technology
Funding Round, Series A, Seed
Japan, United States

Portfolio highlights

Gecipe — Gecipe is a video service for e-sports players.
Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Renalys Pharma — Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Investment focus

Health Care, Medical, Biotechnology
Series A, Series B, Seed
China, United States, Taiwan

Portfolio highlights

AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Lucion is an influential professional venture capital institute.

Investment focus

Biotechnology, Medical, Manufacturing
Series A, Series B, Seed
China

Portfolio highlights

Tota Info — Tota Info is an intelligent technology company that provides integrated hardware and software manufacturing solutions for smart factories in the semiconductor industry.
Runfu Power — Runfu Power is a planetary roller screw R&D manufacturer, committed to the development and production of planetary roller screws.
Northern Hemisphere Technology — Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.

Senshu Ikeda Capital offers financial consultancy services.

Investment focus

Software, Internet, Information Technology
Funding Round, Seed, Series A
Japan

Portfolio highlights

iYell — iYell Mortgage Platform consists of three pillars, Media that can be used for marketing, Technology to make the procedure more efficient.
Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Good News — Good News is a staffing agency that provides recruitment, public relations, and human resource management services.

Innoangel Fund is an investment firm that invests in early stage companies.

Investment focus

Artificial Intelligence, Manufacturing, Software
Angel, Seed, Series A
China, Canada, Hong Kong

Portfolio highlights

Qianjue Technology — Qianjue Technology is a company that created the first full-stack application-level robot model and offers cloud-based artificial intelligence solutions to robot manufacturers.
Shifang Technology — Shifang Technology is a high-tech enterprise that provides integrated intelligent equipment for manufacturing industries.
Anquan Digital Intelligence — Anquan Digital Intelligence is an internet security technology service provider specializing in network security breach detection and defense, data risk and protection, artificial intelligence.

Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.

Investment focus

Software, Artificial Intelligence, Manufacturing
Series A, Series B, Angel
China, United States, Canada

Portfolio highlights

Neurogin — Neurogin is a bioelectronics company that provides reliable monitoring and auxiliary diagnostic tools for clinical and health institutions and focuses on advanced engineering methods for brain science research and clinical diagnosis.
Taifang Technology — ## Build Setup
NAEN Auto Technology — Shanghai NAEN Auto Technology co.Ltd provides automotive electronics products for automobile manufacturers.

The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.

Investment focus

Software, E-Commerce, Artificial Intelligence
Series A, Seed, Series B
Hong Kong, Taiwan, United States

Portfolio highlights

Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
Rice Robotics Limited — The #1 Autonomous Workforce Provider in Hong Kong. Made and Designed in Hong Kong.
BioMed Technology Holdings — BioMed offer a comprehensive service that includes a range of sophisticated tests performed by professionals, together with an interpretation and recommendations for how to live a healthy life.

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Investment focus

Manufacturing, Biotechnology, Health Care
Series A, Series B, Seed
China, Singapore, Norway

Portfolio highlights

Metanovas Biotech — Metanovas is a metabolic drug developer focused on combining artificial intelligence with life sciences, using deep learning.
kaye technology — Kaye Technology is a company that provides automation upgrade solutions for beverage equipment.
Lingchu Intelligence — Lingchu Intelligence is an embodied intelligence startup company that specializes in robot skill set training using reinforcement learning algorithms, scenario-based data generation and collection, and the development and implementation of end-to-end solutions for creating an industry-leading general-purpose dexterous operating intelligent entity.

Danen Ventures is an early-stage venture capital firm that focuses on high-growth fields, such as information technology and internet, renewable energy and environmental, advanced manufacturing industry, biotechnology and medical science, and healthcare.

Investment focus

B2B, Fashion, Medical
Series A, Angel, Seed
China, United States

Portfolio highlights

SynMetaBio — SynMetaBio is a company that develops synthetic biological materials, combining synthetic biology and material design. Their business modules include bio-based medical beauty, functional recombinant proteins, and medical aesthetic materials, including bionic bio-based leather.
Meiyou Technology — Meiyou Technology is a DNA synthesizer developer focusing on enzymatic long-fragment DNA synthesis and splicing technology. They use high-throughput synthesizers to reduce DNA synthesis costs and offer gene design services for the biotechnology industry.
01 Life Science and Technology — Shenzhen is a high-tech firm dedicated to the application of human micro-ecological technology to develop solutions for a healthy life. It also offers solutions for clinical research and diagnosis and treatment of diseases. It was stablished in 2016 and is based in Shenzhen, Guangdong, China.

Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Kenya

Portfolio highlights

Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Alamar Biosciences — Next-gen proteomic platform with ultra-high sensitivity and multiplexing capability for plasma protein detection and liquid biopsies.
Leadsynbio — Pilot Bio is a bio-manufacturing technology research and development company, focusing on bio-manufacturing of major chemical products, bio-process substitution in heavy-polluting industries, etc., providing users with bio-catalytic synthesis processes, enzyme product research and development, production, sales, and downstream companies with enzymeengineering , Technical service outsourcing and production service outsourcing of strain transformation and metabolic engineering.

Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.

Investment focus

Software, Health Care, Information Technology
Series B, Series A, Series C
United States, China, India

Portfolio highlights

Laurus Bio — Laurus Bio offers precision fermentation expertise as a service to customers engaged in microbial fermentation-based manufacturing and product development. They manufacture animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements. Their solutions include cultured meat, cell culture media, biologics and insulinmanufacturing, vaccine, stem cell culture, and regenerative medicine.
Lighthouse — Lighthouse transforms complexity into confidence with actionable insights, business intelligence & pricing solutions that maximize revenue.
Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.

Eisai is a pharmaceutical company that researches and delivers medicines for patients.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series C, Funding Round
Japan, United States, China

Portfolio highlights

Seed Therapeutics — Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
LIFENET INSURANCE COMPANY — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
China, United States, Japan

Portfolio highlights

Sensview — Sensview specializes in the development and production of solid-state imaging chips and detector modules.
Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.

Our team invests in early-stage digital health and consumer startups at CentreGold Capital.

Investment focus

Medical Device, Artificial Intelligence, Internet
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
Virgo Surgical Video Solutions — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.

Orient Securities Capital Investment is an private equity fund business platform.

Investment focus

Health Care, Manufacturing, Software
Series A, Series D, Series C
China

Portfolio highlights

News Dart — News Dart is a manufacturer of precision planetary reducers and helps promote automation and intelligence transmission solutions.
HiStarlink — HiStarlink is a commercial company that makes communication technology like space-borne laser communication terminals and core devices. The main product matrix covers aerospace Advanced core optoelectronic devices, ultra-high-speed communication algorithms, laser communication terminals, and satellite-to-ground laser ground receiving systems.
Shiyu Precision — Shiyu Precision is a high-tech enterprise specializing in the research, development and manufacture of semiconductor automation equipment.

Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.

Investment focus

Software, Manufacturing, Information Technology
Series A, Series B, Seed
China, United States

Portfolio highlights

Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
Mufan Power — Mufan Power is a new energy high-tech enterprise in the field of turbomachinery. It is committed to the development of a new generation of zero-carbon hydrogen power generation technologies and products. Its main products are hydrogen gas turbines, which can be used in distributed energy and data centers. , rail transit, ship power, vehicle power,energy storage peak shaving and other carbon neutral scenarios.
Spectrum-Dynamics — attenuation correction, deep learning, stress test, CTLC, Nuclear Medicine, Digital SPECT, CZT

Loyal Valley Capital is a thematic, research-driven private equity firm.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Series C, Series B, Series A
China, United States, Hong Kong

Portfolio highlights

Chabaidao — Chabaidao is a tea drink brand that aims to create surprises through product development and trendy gameplay.
DP Technology — DP Technology is a global leader in the "AI for Science" research paradigm, where AI learns scientific principles and data, then tackles key challenges in scientific research and industrial R&D.DP's commitment to interdisciplinary research has led to the creation of the DP "Particle Universe", an array of pre-trainedlarge science models designed to bridge foundational research with practical industrial applications. DP's software suite includes the Bohrium® Scientific Research Space, Hermite® Computational Drug Design Platform, RiDYMO® Dynamics Platform, and Piloteye® Battery Design Automation Platform. Together, these platforms form a robust foundation for industrial innovation and an open ecosystem for AI in science, fostering advancements in key areas such as drug discovery, energy, material science, and information technology.
DP Technology — Deep Technology uses a new generation of molecular simulation technology to tackle micro-scale industrial design difficulties. Founded in 2018 and is based in Beijing China.

They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.

Investment focus

Health Care, Biotechnology, Medical
Series A, Series B, Seed
China, United States, Portugal

Portfolio highlights

Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.

Real Tech Japan is a venture capital firm that seeks to invest in innovative R&D technology companies. Realtech Fund is a joint venture between the Ministry of Economy, Trade, and Industry and NEDO (New Energy and Industrial Technology Development Organization). The firm was founded in 2014 and based in Tokyo, Japan.

Investment focus

Manufacturing, Biotechnology, Medical
Funding Round, Series A, Seed
Japan, Singapore, Austria

Portfolio highlights

Ashirase — Ashirase is a developer of a walking navigation system for the visually challenged. The company assists visually impaired people in walking independently. This also allows the user to have more attention to spare for audible warnings in their environment. It includes voice input and guidance via a smartphone app. A vibration interface is attachedto their shoes.
Ken Robotec — Ken Robotec is a construction company that provides labor-saving solutions.
MaterialGate — MaterialGate focuses on single-molecule dielectrics, developing technologies for devices with better electronic characteristics.

BMC engaged in asset management, investment management and consulting.

Investment focus

CAD, Medical, Computer
Seed, Series B
China

Portfolio highlights

Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
Suzhou Pelotin Biotechnology — Suzhou Pelotin Biotechnology is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.
Timesintelli — Timesintelli focuses on the development of various end-side artificial intelligence processing chips. The company provides support for a wide range of end-side devices, such as voice, vision, image, display, and other multi-modal intelligent human-computer interactions. Starting from the needs of the landing scene, through the domain-specificarchitecture and customized chip design in the AIoT era where everything is connected.

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

Investment focus

Information Technology, Software, Internet
Funding Round, Series A, Series B
Japan, United States, China

Portfolio highlights

Precal — Precal is an information technology company that develops applications that are common with pharmacies, pharmacists, and dispensing clerks.
Any — any. develops and offers knowledge sharing tool Qast.
Grand Central — Grand Central is a consulting company specializing in the sales field.

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Investment focus

Health Care, Biotechnology, Software
Series A, Series B, Series C
China, United States, Hong Kong

Portfolio highlights

Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
Zhongcheng Technology — Zhongcheng Technology is a centralized lubrication system developer that focuses on the research and development, manufacturing, sales, and technical services of centralized lubrication systems.
Titanium Robotics Technology — Titanium Robotics Technology specializing in the development and production of advanced robot hardware and solutions. It focuses on customized services, R&D, and production of robot hardware, aiming to create high-performance, industry standard products, develops lightweight, collaborative robots, humanoid robots, and exoskeletons, leading thesupply chain towards lightweight, miniaturization, and ease of use.

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Investment focus

Health Care, Medical, Biotechnology
Series A, Seed, Series B
China, United States

Portfolio highlights

ZD Medical — ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes.
Puju Biotechnology — PuJu Biotech focuses on developing an engineering process platform for bioactive filling materials and is dedicated to continuously launching world-class high-end regenerative medicine material products to benefit the vast number of people seeking beauty, as well as providing new material solutions for medical beauty and anti-aging for all agegroups.
Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Series C
China, United States, Hong Kong

Portfolio highlights

Syneron — Syneron was founded by Sinovation Ventures and is dedicated to using artificial intelligence and biotechnology to address two significant global challenges: the efficient development of novel biological therapies and the low-carbon manufacture of biochemicals.
Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
Avenzo Therapeutics — Developing the next generation of oncology therapies for patients.

BOHE Angel Fund is an investment Fund.

Investment focus

Health Care, Medical, Biotechnology
Angel, Series A, Seed
China

Portfolio highlights

QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
Tyligand Bioscience — Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes.
Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Investment focus

Information Technology, Software, Financial Services
Series B, Funding Round, Series A
Japan, South Korea, United States

Portfolio highlights

BasiGo — BasiGo is an early-stage e-mobility start-up looking to revolutionize the public transportation sector by providing matatu owners with a cost-effective electric alternative to diesel buses.
AI model — AI model specializes in the development and transformation of real-like virtual models for modeling on E-commerce platforms.
Ultra Social — Ultra Social offers marketing support, management creator production, and tiktok live production services.

Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.

Investment focus

Health Care, Medical, Manufacturing
Series A, Series B, Seed
China, United Kingdom, United States

Portfolio highlights

DeepWay — DeepWay is a maker and developer of intelligent electric commercial vehicles.
Aptech — Aptech is a creative firm focused on cutting-edge biotechnology, with a strong scientific research foundation from first-rate domestic scientific research institutions and substantial backing.
Dragonfly Wings — Dragonfly Wings is an eVTOL tilt-wing company that specializes in the development, R&D, production, and sales of tiltrotor eVTOL.

Investors by industry